BIGNUCOLO, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 569
AS - Asia 89
EU - Europa 58
OC - Oceania 5
Totale 721
Nazione #
US - Stati Uniti d'America 569
CN - Cina 78
IT - Italia 30
FI - Finlandia 9
SG - Singapore 7
DE - Germania 6
AU - Australia 5
GB - Regno Unito 5
UA - Ucraina 3
HK - Hong Kong 2
IE - Irlanda 2
IN - India 2
HR - Croazia 1
NL - Olanda 1
SE - Svezia 1
Totale 721
Città #
Fairfield 107
Chandler 90
Ashburn 42
Cambridge 40
Seattle 36
Beijing 35
Woodbridge 34
Houston 22
Wilmington 21
Medford 15
Princeton 15
Padova 14
Des Moines 12
New York 12
Helsinki 9
San Diego 9
Ann Arbor 8
Cagliari 6
Philadelphia 6
Roxbury 6
Jinan 5
Melbourne 5
London 4
Los Angeles 4
Nanjing 4
Atglen 3
Singapore 3
Dublin 2
Fuzhou 2
Hebei 2
Kharkiv 2
Kowloon 2
Norwalk 2
Shenyang 2
Taizhou 2
Atlanta 1
Boardman 1
Borås 1
Council Bluffs 1
Haikou 1
Hangzhou 1
Lutsk 1
Nanchang 1
Ogden 1
San Vito Al Tagliamento 1
Shanghai 1
Taiyuan 1
Tucson 1
Utrecht 1
Zagreb 1
Totale 598
Nome #
Genetic markers of the host to predict the efficacy of colorectal cancer targeted therapy 70
Pharmacogenomics of targeted agents for personalization of colorectal cancer treatment 64
FARMAPRICE: A Pharmacogenetic Clinical decision support system for precise and Cost-Effective Therapy 63
Genetic biomarkers for hepatocellular cancer risk in a caucasian population. 61
Germline Polymorphisms in the Nuclear Receptors PXR and VDR as Novel Prognostic Markers in Metastatic Colorectal Cancer Patients Treated With FOLFIRI 56
Association of STAT-3 rs1053004 and VDR rs11574077 With FOLFIRI-related gastrointestinal toxicity in metastatic colorectal cancer patients 54
The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice 51
PREEMPTIVE PHARMACOGENOMIC TESTING FOR PREVENTING ADVERSE DRUG REACTIONS (PREPARE): STATE OF ART AND PRELIMINARY RESULTS ON GENOTYPE ACTIONABILITY 45
Resveratrol in cancer patients: From bench to bedside 44
Il15ra and smad3 genetic variants predict overall survival in metastatic colorectal cancer patients treated with folfiri therapy: A new paradigm 43
Development of an Integrated Health IT Platform for a Precision Medicine Setting 36
Uso di marcatori farmacogenetici per migliorare la sicurezza e l'efficacia dei trattamenti antiblastici all'interno dello studio di implementazione delle linee guida PGx PREPARE 30
DEVELOPMENT OF AN INTEGRATED HEALTH IT PLATFORM FOR A PRECISE AND COST-EFFECTIVE THERAPY IN ONCOLOGY 29
SMAD3 Host and Tumor Profiling to Identify Locally Advanced Rectal Cancer Patients at High Risk of Poor Response to Neoadjuvant Chemoradiotherapy 25
Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results 24
Sex disparities in efficacy in covid-19 vaccines: A systematic review and meta-analysis 15
Evaluation of Concomitant Use of Anticancer Drugs and Herbal Products: From Interactions to Synergic Activity 10
The Multiple Effects of Vitamin D against Chronic Diseases: From Reduction of Lipid Peroxidation to Updated Evidence from Clinical Studies 10
Integrative oncology: evidence-based medicine - The multidisciplinary experience of the Integrative Medicine Research Group (IMRG) 9
Totale 739
Categoria #
all - tutte 3.865
article - articoli 3.596
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020132 0 0 0 0 0 0 27 22 28 35 20 0
2020/2021106 11 1 26 1 19 3 3 0 26 3 4 9
2021/2022175 2 33 15 7 5 8 18 14 7 7 16 43
2022/2023173 28 20 1 18 29 27 0 14 18 1 16 1
2023/2024153 4 11 18 11 8 38 20 20 2 8 13 0
Totale 739